EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christian Latremouille
Alain Carpentier
Jean-Noël Fabiani
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grinda, J.-M.
Right arrow Articles by Deloche, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grinda, J.-M.
Right arrow Articles by Deloche, A.
Related Collections
Right arrow Valve disease

Eur J Cardiothorac Surg 2002;21:447-452
© 2002 Elsevier Science NL

Triple valve repair for young rheumatic patients

Jean-Michel Grinda*, Christian Latremouille, Nicola D'Attellis, Alain Berrebi, Sylvain Chauvaud, Alain Carpentier, Jean-Noël Fabiani, Alain Deloche

Cardiac Surgery Department, Hôpital Européen Georges Pompidou, Paris University, 21 rue Leblanc, 75908 Paris cedex 15, France

Received 5 October 2001; received in revised form 13 December 2001; accepted 19 December 2001.

* Corresponding author. Tel.: +33-1-5609-3624; fax: +33-1-5609-2219
e-mail: jean-michel.grinda{at}egp.ap-hop-paris.fr


    Abstract
 Top
 Abstract
 1. Introduction
 2. Patients and methods
 3. Results
 4. Discussion
 References
 
Background: Facing young foreign polyvalvular rheumatic patients, for which long-term anticoagulation is not available, we have chosen to attempt triple valve repair procedures in order to avoid prosthetic implantation in this particular population suffering from triple valve disease. Methods: Twenty-one young rheumatic patients (mean age:11±4 years) underwent triple valve repair procedures including cusp extension on the aortic valve aortic between September, 1992 and December, 2000. Valvular pathology characteristics according to Carpentier's classification included mitral insufficiency type III post+II ant (n=10), type III post (n=4), type II ant (n=2), mitral stenosis (n=5), type III aortic insufficiency (n=21), type I (n=13) and type III (n=8) tricuspid insufficiency. Results: Firstly, the mitral valve disease were corrected using Carpentier's techniques of repair: prosthetic ring annuloplasty (n=16), commissurotomy (n=12), chord transposition (n=11) or shortening (n=4), papillary muscle sliding plasty (n=4) and pericardial patch leaflet enlargement (n=6). Secondly, aortic lesions were corrected using glutaraldehyde stabilized autologous pericardium triple cusps extension technique (n=21). Lastly, tricuspid repairs were always performed on beating hearts using commissurotomy (n=8), prosthetic ring (n=12) or other techniques (n=9) of annuloplasty. The operative mortality was 4.7% (one patient died). Echocardiograms before discharge showed grade I mitral insufficiency in seven patients and grade I aortic insufficiency in five patients. There was no late death during a mean follow-up of 51±31 months. Two patients underwent valvular redo surgery because of aortic and mitral plasty deterioration due to rheumatic disease progress. After 5 years, 90% of the patients were free from redo valvular surgery. Conclusions: In rheumatic patients, autologous pericardial patch extension of the aortic valve permitted widespread use of reconstructive surgery even in patients suffering from triple valve disease. Triple valve repair, in this particular challenging setting of patients, has provided satisfactory initial and mid-term results and could be considered as an interesting palliative surgical approach.

Key Words: Valvular disease • Rheumatic disease • Valvular surgery • Reconstructive valvular surgery


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Patients and methods
 3. Results
 4. Discussion
 References
 
Rheumatic diseases are dramatically decreasing in the Western world, where rheumatic patients are usually elderly patients with calcified lesions requiring valvular replacement unless they are redos of valvular replacement for prosthesis deterioration or dysfunction. Nevertheless, rheumatic disease is still the main cause of valvulopathy in non-industrialized nations and often affect young patients. Bioprotheses are not an ideal substitute in the young; additionally, sanitary conditions in these countries do not allow long-term anticoagulation. Rheumatic mitral valve disease in the young is usually accessible to reconstructive surgery. The accessibility of the diseased aortic valve to the pericardial cusp extension technique of repair has allowed us to offer a triple valve repair procedure to young patients with triple valve disease.


    2. Patients and methods
 Top
 Abstract
 1. Introduction
 2. Patients and methods
 3. Results
 4. Discussion
 References
 
2.1. Patients
Between September 1992 and December 2000, 21 young patients suffering from rheumatic disease underwent triple valve repair procedure, including pericardial patch extension of the aortic valve, at our institution (see Table 1). There were 13 males and eight females, and ages ranged from 6 to 16 years (mean age 11±4 years). All of these patients originated from developing countries and were treated with the help of a humanitarian association. Countries of origin were located in Southeast Europe (n=1), North Africa (n=5), West Africa (n=6) or Southeast Asia.(n=9). Two patients were in New York Heart Association (NYHA) Functional Class II, six in Class III and 13 in Class IV. Malnutrition was present in eight patients (38%) No patient had active rheumatic myocarditis on the basis of clinical and laboratory examination.


View this table:
[in this window]
[in a new window]
 
Table 1. Valvular pathology characteristics

 
2.2. Echocardiograms
All patients had transthoracic echocardiograms (TTE) and Doppler examinations at our institute to quantify and determine the type of valve disease according to Carpentier ‘s classification [1], and to evaluate the possibility of valve repair. Transesophageal echocardiograms (TEE) were always performed intraoperatively in patients having a mass greater than 30 kg and from 1998 in all patients regardless of mass. Triple valve disease was confirmed in all patients.

2.2.1. Mitral valve diseases
Sixteen patients had mitral valve insufficiency (grade III=5, grade IV=11); seven of them had an associated mitral stenosis. Most of the patients with mitral valve insufficiency had mitral annulus deformation with restriction of the posterior leaflet and some prolapse of the anterior leaflet (type II ant, III post), which are the most common mitral dysfunctions encountered in the young rheumatic patient. Five patients had pure mitral stenosis (mean transmitral gradient=12±4 mmHg).

2.2.2. Aortic valve disease
All patients had type III aortic insufficiency (grade II=2, grade III=9, grade IV=10) due to aortic cusp retraction resulting in central triangular coaptation defect on echocardiography.

2.2.3. Tricuspid valve disease
Eight patients had an organic tricuspid valve disease resulting in type III tricuspid valve insufficiency (grade III=4, grade IV=4), and 13 patients had a functional type I tricuspid valve insufficiency (grade III=3, grade IV=10).

2.3. Surgical procedure
The operative procedures are summarized in Table 2.


View this table:
[in this window]
[in a new window]
 
Table 2. Operative procedure

 
Before cardiopulmonary bypass (CPB), autologous pericardium patches were harvested, carefully thinned down and stabilized with glutaraldehyde [2,3] (8 min in a 0.62% glutaraldehyde solution). CPB was performed between the ascending aorta and both venae cavae. Myocardial protection was achieved with cold crystalloid cardioplegia injected into the coronary ostia, topical cooling of the heart and systemic moderate hypothermia (28 °C). The mitral lesions were corrected first through left atriotomy using standardized Carpentier's technique of repair [1], secondly the aortic lesions were corrected using the autologous pericardium cusp extension technique [46] and lastly the tricuspid valves were corrected on beating heart. Aortic occlusion time ranged from 43 to 180 min (mean 101±34 min) and CPB time ranged from 70 to 240 min (mean 127±44 min).

Techniques used to achieve mitral valve repair were: prosthetic mitral annuloplasty using Carpentier rings in 16 patients (the size of which were no. 26=1, no. 28=7, no. 30=6, no. 32=2), commissurotomy (12 patients), chord transposition from posterior to the anterior leaflet or secondary chord transposition to the free anterior leaflet edge (11 patients), chord shortening (four patients), papillary muscle sliding plasty (four patients), pericardial patch enlargement of the posterior mitral leaflet (four patients) or of the anterior mitral leaflet (two patients).

Aortic repair was then attempted. Three rectangular strips, the height of which was 8 mm with length adjusted according to the length of each aortic free edge cusp, were tailored in the previously harvested pericardium. Each autologous pericardial strip was then sutured to the corresponding free edge of the aortic cusp using 7-0 prolene. Starting at the midpoint of the cusp, the suture was prolonged at the commissure, onto the aortic wall, and finally stopped outside with the thread used for the adjacent cusp. The new commissures were then elevated to the height of the autologous pericardial strip (8 mm) (Fig. 1) . The aorta was sutured without any distortion so as not to disturb the architecture of the aortic valve reconstruction.



View larger version (127K):
[in this window]
[in a new window]
 
Fig. 1. Aortic cusp extension valvuloplasty

 
Tricuspid repair was always performed under beating heart through an oblique right atriotomy. Tricuspid annuloplasty was achieved with Carpentier's prosthetic ring in 12 patients (the size of which were no. 28=3, no. 30=4, no. 32=5) and De Vega techniques in nine patients. Tricuspid commissurotomy was performed in eight patients.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Patients and methods
 3. Results
 4. Discussion
 References
 
3.1. Primary failure
Primary failure of triple valve repair did not occur.

3.2. Mortality
A 14-year-old child in preoperative NYHA Class IV died because of multi-organ failure (MOF) on postoperative day 27 (operative mortality: 4.7%).

3.3. Morbidity
Hospital complications included: MOF syndrome (n=1), low cardiac output (n=2), pneumothorax (n=1), septicemia (n=1). Mean postoperative ICU stay was 2.4±4 days (range 1–19 days).

3.4. Echocardiograms
Before 1998, intraoperative TEE was only available in patients weighing more than 30 kg, and from 1998 TEE was available in all patients. However, all of the patients underwent TTE control before discharge. Five patients had no more than grade I residual aortic insufficiency; mean postoperative gradient on the aortic extended valve was 8.2±3.7 mmHg. Seven patients had no more than a grade I mitral insufficiency; no patient had no more than grade I tricuspid valve insufficiency on control.

3.5. Follow-up
All of the surviving patients went back to their countries after surgery. In each country, one referring local physician or cardiologist was able to assess the patient's condition on the basis of physical examination and, depending on technical possibility, on the basis of TTE. In such conditions we cannot provide a uniform TTE follow-up protocol as we would have liked. One patient was lost from follow-up because of political instability in his country. Mean follow-up was 51±31 months (range 1–92 months).

3.6. Late death
No patient died during follow-up.

3.7. Redo surgery
Two patients underwent valvular redo surgery during follow-up. These two patients had pericardial patch enlargement of the anterior mitral leaflet during initial repair due to a high degree of leaflet thickening and retraction. They had significant progression or reactivation of rheumatic disease. An 11-year-old male child had a significant progression of rheumatic disease responsible for mitral and aortic valvuloplasty deterioration. He underwent an aortic homograft replacement and two unsuccessful mitral repairs before prosthetic mitral valve replacement during postoperative month 14. In the second, a 16-year-old male child, a redo mitral plasty associated with aortic homograft procedure was attempted. Because of redo mitral valvuloplasty unfeasibility, a double prosthetic valve replacement was successfully performed during postoperative month 32.

3.8. Anotomopathology of the extended aortic valve
The explanted native aortic cusp and pericardial patches were studied, including histologic studies with hematoxylin-eosin-safran, blue alcian and orceine colorations for the nucleus, cytoplasm and conjunctive tissues, respectively, and for mucopolysaccharide and elastic fiber. In the first patient, only orceine coloration allowed distinction between native aortic cusp and pericardial patches in severe sclerosis with important neovascularization and mononuclear inflammatory infiltration. In the second patient, the aortic reparation architecture was conserved. Native cusp, suture and patches were clearly distinguishable (Fig. 2) . Aortic cusp showed chronic rheumatic process. Patches showed moderate retraction, fibrosis and rare small calcifications. The pericardium contained very few spindle cells of fibroblast appearance with abundant extracellular matrix. No endothelial layer was observed covering the surface of the pericardium



View larger version (132K):
[in this window]
[in a new window]
 
Fig. 2. Gross pattern of the three treated cusp showing severe fibrous thickening, organization of the pericardial patches within this fibrosis

 
3.9. Clinical status
All patients are in NYHA Class II or I. No bacterial endocarditis events occurred during follow-up. Long-term anticoagulation was used in three patients (the two patients with prosthetic valves and another one because of atrial fibrillation). In regard to the effectiveness of anticoagulation, no thromboembolic events have occurred.

3.10. Echocardiograms
The 17 patients present at follow-up with triple valve repairs underwent TTE in their country.

Three patients experienced deterioration in the quality of the valve repairs, during postoperative months 37, 48 and 58, respectively. All had moderate deterioration of mitral and aortic repair responsible for grade II mitral and aortic valve regurgitation.


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Patients and methods
 3. Results
 4. Discussion
 References
 
Triple valve repair has appeared as a feasible surgical approach in this particular setting of severe young rheumatic patients in which long-term anticoagulation is not available. The mortality rate in this group is not higher than the previous reported group in which prosthetic valves were used. [710]

Mitral as well as tricuspid valve repair feasibility has been well demonstrated in young rheumatic patients [1]. The most common mitral dysfunction in rheumatic patients is posterior leaflet restricted motion which can be corrected using the standard Carpentier technique of repair (secondary chord resection for posterior leaflet mobilization or pericardial patch extension of the posterior leaflet). Pericardial patch enlargement [2,3] is attractive in the case of severe retraction of the posterior leaflet, allowing effective leaflet enlargement and one to two higher size prosthetic ring insertions. We reserved anterior pericardial patch enlargement to retraction of the anterior leaflet encountered in particularly severe rheumatic mitral valve disease. Except in case of associated endocarditis damage, prolapse is not the predominant dysfunction encountered in rheumatic disease. The most usual lesion encountered is an increased space between the paramedian chords resulting in some degree of prolapse of median free edge anterior leaflet. This lesion can be corrected by anterior secondary chord transposition at the midpoint of the anterior leaflet free edge. The other lesions encountered are chord elongation or papillary muscle elongation, which can be corrected by chord shortening or papillary muscle sliding plasty.

The pericardial aortic cusp extension technique of repair has been developed by Duran et al. [46]. We have adopted a simplification of the initial technique which appears to be adapted to the most common lesions in rheumatic aortic valve insufficiency: cusp retraction resulting in central regurgitation that requires leaflet extension to increase the area of leaflet coaptation [4].

The long-term outcome of this triple valvular plasty is uncertain. The material of choice for extension is still debated [46,11]. Glutaraldehyde-stabilized autologous pericardium that we used has provided good initial and mid-term results. But patches could retract and in previously reported groups, the reintervention rate of aortic extension has been about 10% [6,12]. In fact in our group all valvular reoperations (rate of which was 10%) were due to progression of rheumatic disease, which is known to be the main cause of reoperation after surgical valvuloplasty in rheumatic patients, particularly in the young [13].

However, ideal surgical alternative techniques are not available because of the lack of ideal valve substitutes for the young and particularly in this setting of young rheumatic foreign patients that cannot have long-term anticoagulation [14,15]. Homografts still have antigenic properties and less durability when implanted in the young than in adult populations, as has already been reported [16,17]. The Ross procedure is a more technically demanding, more time-consuming procedure with concerns regarding the issue of the homograft pulmonary valve replacement [18,19], and limited benefits have been reported with the Ross procedure in young rheumatic patients [20]. We have not associated this procedure with double mitral and tricuspid valvuloplasty. We usually completed mitral valvuloplasty by aortic homograft implantation, when aortic repair was not accessible with the cusp extension technique because of pericardial adhesion, cusp prolapse, calcification or excessive thickness. On the other hand, when mitral repair was unfeasible, which is particularly rare in this setting of young patients, double valve replacement was necessarily required. Because of deceptive results we encountered with the mitral homograft in the young we now do not use this technique [21] in this situation.

Of course, the problem is different with patients originating from the Western world in which long-term anticoagulation is available. However, triple valvuloplasty could be interesting as a palliative procedure while awaiting native annulus growth, especially in the aortic annulus in children, or awaiting a less critical period for definitive anticoagulation.


    Footnotes
 
Presented at the joint 15th Annual Meeting of the European Association for Cardio-thoracic Surgery and the 9th Annual Meeting of the European Society of Thoracic Surgeons, Lisbon, Portugal, September 16–19, 2001.


    References
 Top
 Abstract
 1. Introduction
 2. Patients and methods
 3. Results
 4. Discussion
 References
 

  1. Carpentier A. Cardiac valve surgery: the French correction. J Thorac Cardiovasc Surg 1983;86:323-337.[Medline]
  2. Chachques J.C., Vasseur B., Perrier P., Balansa J., Chauvaud S., Carpentier A. A rapid method to stabilize biological materials for cardiovascular surgery. Ann N Y Acad Sci 1988;529:184-186.
  3. Chauvaud S., Jebara V., Chachques J.C. Valve extension with glutaraldehyde-preserved autologous pericardium. J Thorac Cardiovasc Surg 1991;102:171-178.[Abstract]
  4. Duran C., Kumar N., Gometza B., Al-Halees Z. Indications and limitations of aortic valve reconstruction. Ann Thorac Surg 1991;52:447-454.[Abstract]
  5. Duran C.M.G., Gometza B., Kumar N., Gallo R., Martin-Duran R. Aortic valve replacement with freehand autologous pericardium. J Thorac Cardiovasc Surg 1995;110:511-516.[Abstract/Free Full Text]
  6. Duran C.M.G., Gallo R., Kumar N. Aortic valve replacement with autologous pericardium: surgical technique. J Card Surg 1995;10:1-9.[Medline]
  7. Robbins R.C., Bowman F.O., Jr, Malm J.R. Cardiac valve replacement in children: a twenty-year series. Ann Thorac Surg 1988;45:56-61.[Abstract]
  8. Galloway A.C., Grossi E.A., Baumann F.G., LaMendola C.L., Crooke G.A., Harris L.J., Colvin S.B., Spencer F.C. Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients. J Am Coll Cardiol 1992;19:725-732.[Abstract]
  9. Jones E.L., Ravikumar E., Jairaj P.S., Chowdhury U., Krish-naswami S. Valve replacement in the young patient with rheumatic heart disease. J Thorac Cardiovasc Surg 1990;99:631-639.[Abstract]
  10. Prabhakar G., Kumar N., Gometza B., Pharm D., Galal O., Al-Halees Z., Duran M.G. Triple valve operation in the young rheumatic patient. Ann Thorac Surg 1993;55:1492-1496.[Abstract]
  11. Kalengos A., Beghetti M., Baldovinos A., Vala D., Bichel T., Mennillod B., Murith N., Oberhanski I., Friedli B., Faidutti B. Aortic valve repair by cusp extension with the use of fresh autologous pericardium in children with rheumatic aortic insufficiency. J Thorac Cardiovasc Surg 1999;118:225-236.[Abstract/Free Full Text]
  12. Haydar H.S., He G.W., Hovaguimian H., McIrvin D.M., King D.H. Valve repair for aortic insufficiency: surgical classification and techniques. Eur J Cardiovasc Surg 1997;11:259-265.
  13. Deloche A., Jebara V.A., Relland J.Y.M., Chauvaud S., Fabiani J.N., Dreyfus G., Mihaileanu S., Carpentier A. Valve repair with Carpentier techniques. The second decade. J Thorac Cardiovasc Surg 1990;99:990-1002.[Abstract]
  14. Walker W.E., Duncan J.M., Frazier O.H., Jr, Livesay J.J., Ott D.A., Reul G.J., Cooley D.A. Early experience with Ionescu-Shiley pericardial xenograft valve: accelerated calcification in children. J Thorac Cardiovasc Surg 1983;86:570-575.[Abstract]
  15. Bradley S.M., Sade R.M., Crawford F.A., Stroud M.R. Anticoagulation in children with mechanical valve prostheses. Ann Thorac Surg 1997;64:30-36.[Abstract/Free Full Text]
  16. Yacoub M., Rasmi N.R.H., Sundt T.M., Lund O., Boyland E., Radley-Smith R., Khaghani A., Mitchell A. Fourteen year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-194.[Abstract/Free Full Text]
  17. Weipert J., Meisner H., Mendler N., Haehnel J.C., Homann M., Paek S.U., Sebening F. Allograft implantation in pediatric cardiac surgery: surgical experience from 1982 to 1994. Ann Thorac Surg 1995;60(2 Suppl):S101-S104.
  18. Matsuki O., Okita Y., Almeida R.S., McGoldrick J.P., Hooper T.L., Robles A., Ross D.N. Two decades’ experience with aortic valve replacement with pulmonary autograft. J Thorac Surg 1988;95:705-711.[Abstract]
  19. Gerosa G., McKay R., Ross D.N. Replacement of the aortic valve or root with a pulmonary autograft in children. Ann Thorac Surg 1991;51:424-429.[Abstract]
  20. Choudhary S.K., Mathur A., Sharma R., Saxena A., Chopra P., Ro Kumar A.S. Pulmonary autograft: should it be used in young patients with rheumatic disease. J Thorac Cardiovasc Surg 1999;118:483-491.[Abstract/Free Full Text]
  21. Acar C., Tolan M., Berrebi A., Gaer J., Gouezo R., Marchix T., Gerota J., Chauvaud S., Fabiani J.N., Deloche A., Carpentier A. Homograft replacement of the mitral valve. J Thorac Cardiovasc Surg 1996;111:367-380.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
T. Kazui, H. Kin, H. Izumoto, T. Nakajima, K. Ishihara, and K. Kawazoe
Combined Aortic and Mitral Valve Repair
Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 319 - 322.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christian Latremouille
Alain Carpentier
Jean-Noël Fabiani
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grinda, J.-M.
Right arrow Articles by Deloche, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grinda, J.-M.
Right arrow Articles by Deloche, A.
Related Collections
Right arrow Valve disease


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS